IL6 and vitiligo: The IHC-positive areas of IL-6 and TNF-α of the FHB high-dose treatment group (HQ+7.2g/kg FHB) were even lower than those of the control group, indicating that FHB strongly inhibited inflammation in the topical vitiligo skin (Figures 8B, C).